Author: Forum on Drug Discovery

Despite the extensive body of evidence that informs regulatory decisions on pharmaceutical products, significant uncertainties persist, including t...

Randomized clinical trials (RCTs) are often referred to as the gold standard of clinical research. However, in its current state, the U.S. clinical...

Advances in technologies and knowledge are creating new avenues for research and opportunities for the discovery and clinical development of innova...

To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this inf...

The use and misuse of antibiotics contributes to the rise in drug-resistant bacteria - a serious and worsening threat to human health. The developm...

Emerging infectious disease threats that may not have available treatments or vaccines can directly affect the security of the world's health since...

An ideal health care system relies on efficiently generating timely, accurate evidence to deliver on its promise of diminishing the divide between ...

The past several decades have been a time of rapid globalization in the development, manufacture, marketing, and distribution of medical products a...

There is a void in evidence-based information for making informed decisions on how to optimize care for older adults, particularly those 80 years a...

Those involved in the drug development process face challenges of efficiency and overall sustainability due in part to high research costs, lengthy...

The use of immune modulator therapeutics, a type of immunotherapy enhancing the body immune system response to cancer, was perceived as the beginni...

Tuberculosis (TB) kills approximately 4,500 people worldwide every day. While most cases of TB can be treated with antibiotics, some strains have d...

During public health emergencies such as pandemic influenza outbreaks or terrorist attacks, effective vaccines, drugs, diagnostics, and other medic...

The process of discovering and developing a new drug or therapy is extremely costly and time consuming, and recently, it has been estimated that th...

On November 18 and 19, 2019, the National Academies of Sciences, Engineering, and Medicine hosted a public workshop in Washington, DC, titled Shari...